ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas
August 20, 2021Marker today announced that the Company received notice of a Product Development Research award totaling approximately $13.1 million from the CPRIT to support the Company's Phase 2 clinical trial of its lead MultiTAA-specific T cell product MT-401. -
CPRIT Awards Forbius Product Development Grant
August 28, 2018Forbius (Formation Biologics) has been awarded a Product Development grant totaling $18.75 million from the Cancer Prevention and Research Institute of Texas (CPRIT).
Pharma Sources Insight January 2025
